霉酚酸酯在肺移植中的应用 - Suppr | 超能文献

Mycophenolate mofetil in lung transplantation.

作者信息

Zuckermann A, Birsan T, Thaghavi S, Artemiou O, Kupilik N, Dekan G, Wolner E, Klepetko W

机构信息

Department of Cardiothoracic Surgery, University of Vienna, Austria.

出版信息

Transplant Proc. 1998 Jun;30(4):1514-6. doi: 10.1016/s0041-1345(98)00339-x.

DOI:10.1016/s0041-1345(98)00339-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Mycophenolate mofetil in lung transplantation.霉酚酸酯在肺移植中的应用

Transplant Proc. 1998 Jun;30(4):1514-6. doi: 10.1016/s0041-1345(98)00339-x.

2

Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.霉酚酸酯与硫唑嘌呤用于接受环孢素治疗的胰肾联合移植受者的比较

Transplant Proc. 1998 Jun;30(4):1562-3. doi: 10.1016/s0041-1345(98)00358-3.

3

Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.低剂量霉酚酸酯联合低剂量他克莫司可预防肺移植术后急性排斥反应及长期功能丧失。

Transplant Proc. 2001 May;33(3):2146-7. doi: 10.1016/s0041-1345(01)01978-9.

4

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.

Transplant Proc. 1999 Nov;31(7):3007-8. doi: 10.1016/s0041-1345(99)00644-2.

5

Immunosuppressive regimen in lung transplantation: initial intravenous mycophenolate mofetil and cyclosporine avoid cytolytic induction and allow for rapid steroid tapering.肺移植中的免疫抑制方案：初始静脉注射霉酚酸酯和环孢素可避免细胞溶解诱导，并允许快速减少类固醇用量。

Transplant Proc. 2002 Aug;34(5):1879-80. doi: 10.1016/s0041-1345(02)03106-8.

6

Tacrolimus-based immunosuppressive protocols in lung transplantation.肺移植中基于他克莫司的免疫抑制方案

Transplant Proc. 1999 Feb-Mar;31(1-2):171-2. doi: 10.1016/s0041-1345(98)01488-2.

7

Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.霉酚酸酯消除了非单倍体活体供肾移植中抗淋巴细胞诱导治疗的理论依据。

Transplant Proc. 1997 Feb-Mar;29(1-2):342-3. doi: 10.1016/s0041-1345(96)00300-4.

8

A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.一项比较霉酚酸酯与硫唑嘌呤在原发性肝移植受者中的安全性和有效性的前瞻性研究。

Transplant Proc. 2000 Nov;32(7):2125-7. doi: 10.1016/s0041-1345(00)01599-2.

9

Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.霉酚酸酯对肺移植后环孢素A诱导的肾病患者的益处。

Transplant Proc. 1999 Feb-Mar;31(1-2):1160-1. doi: 10.1016/s0041-1345(98)01945-9.

10

Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum.

Transplant Proc. 1997 Dec;29(8A):16S-20S. doi: 10.1016/s0041-1345(97)00850-6.

引用本文的文献

1

Eco-friendly reduced graphene oxide for the determination of mycophenolate mofetil in pharmaceutical formulations.用于测定药物制剂中霉酚酸酯的环保型还原氧化石墨烯

J Pharm Anal. 2018 Apr;8(2):131-137. doi: 10.1016/j.jpha.2017.12.001. Epub 2017 Dec 8.

2

Immunosuppression and allograft rejection following lung transplantation: evidence to date.肺移植后免疫抑制和移植物排斥：现有证据。

Drugs. 2013 Nov;73(16):1793-813. doi: 10.1007/s40265-013-0136-x.